Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01700985 · ClinicalTrials.gov registry record · Phase 2
A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis
A Phase 2 study, sponsored by Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT01700985 is a Phase 2 study that has completed, run by Therapeutics. The registered enrollment target is 44 participants.
The verdict
NCT01700985, a Phase 2 study, has completed, sponsored by Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
Corticosteroids are one of the mainstays of treatment for subjects with corticosteroid-responsive dermatoses such as psoriasis. This study has been designed to determine and compare the efficacy and safety of a formulation of 122-0551 versus the corresponding Vehicle in subjects with stable plaque psoriasis after twice daily dosing for 14 consecutive days.
Interventions
- DRUG Vehicle
- DRUG 122-0551
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01700985
The ClinicalTrials.gov registry entry for NCT01700985 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Therapeutics, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT01700985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01700985 about?
NCT01700985 is a clinical study titled "A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis". Corticosteroids are one of the mainstays of treatment for subjects with corticosteroid-responsive dermatoses such as psoriasis. This study has been designed to determine and compare the efficacy and safety of a formulation of 122-0551 versus the corresponding Vehicle in subjects with stable plaque p...
What is the current status of trial NCT01700985?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2012-05. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01700985?
The interventions under investigation include: Vehicle (DRUG), 122-0551 (DRUG).
Who is sponsoring clinical trial NCT01700985?
This trial is sponsored by Therapeutics, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.